Holen Sie sich die Stockscreener-App
61.60
6.70%
3.67
Schlusskurs vom Vortag:
$57.93
Offen:
$57.55
24-Stunden-Volumen:
5.76M
Relative Volume:
0.91
Marktkapitalisierung:
$11.06B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$-302.91M
KGV:
-35.85
EPS:
-1.7182
Netto-Cashflow:
$-219.93M
1W Leistung:
+19.00%
1M Leistung:
+17.06%
6M Leistung:
+4.67%
1J Leistung:
+3.98%
1-Tages-Spanne:
$57.44
$62.58
1-Wochen-Bereich:
$52.57
$62.58
52-Wochen-Spanne:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
61.59 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
186.56 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
68.79 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.09 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
85.34 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Underperform |
| 2026-04-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI (TEM) Holds Steady Near Support Amid Modest PullbackDollar Neutral Pair - dars.gov.et
Does Tempus AI’s (TEM) xH Launch Quietly Redraw Its Long‑Term Data Moat Strategy? - simplywall.st
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI - Yahoo Finance
Correction: Biovica refocuses US commercial strategy and terminates agreement with Tempus AI - TradingView
Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI - TradingView
Biovica refocuses US commercial strategy and terminates agreement with Tempus AI - marketscreener.com
Tempus AI: Buy On Diagnostics Momentum And AI Platform Expansion (NASDAQ:TEM) - Seeking Alpha
Form 4 Tempus AI Inc For: 29 June By Investing.com - Investing.com Canada
Tempus AI CFO James Rogers sells $634,095 in TEM stock - Investing.com UK
Tempus AI CFO James Rogers sells $634,095 in TEM stock By Investing.com - Investing.com Australia
Tempus AI director Jennifer Doudna sells $147,015 in stock By Investing.com - Investing.com Australia
Tempus AI (TEM) CFO sells 11,529 shares under Rule 10b5-1 plan - Stock Titan
Form 144 Tempus AI For: 29 June By Investing.com - Investing.com South Africa
$Tempus AI (TEM.US)$ whats next …. - Moomoo
Tempus AI (NASDAQ: TEM) insiders report multi-holder Class A sales - Stock Titan
Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback - Barchart.com
Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape - DirectorsTalk Interviews
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short Interest - Insider Monkey
Tempus AI (TEM) Expands Rare Cancer Research, Is The Stock Fully Priced? - simplywall.st
5 Worst Artificial Intelligence Stocks Under $30 According to Short Sellers - Insider Monkey
How genetic testing company Tempus AI is using data and artificial intelligence to help personalize cancer care - MSN
Tempus AI Stock (TEM) Opinions on Healthcare AI Breakthroughs - Quiver Quantitative
Tempus AI Stock Short Interest Rises to 38.44% - Quiver Quantitative
Tempus AI, Inc. $TEM Shares Sold by SG Americas Securities LLC - MarketBeat
Tempus AI stock jumps on rare cancer research partnership - Investing.com
Why is Tempus AI stock rallying today? - Investing.com UK
TEM (NASDAQ: TEM) insider resale: 11,529 RSU shares listed for sale - Stock Titan
Why is Tempus AI stock rallying today? By Investing.com - Investing.com Nigeria
Investors Purchase High Volume of Call Options on Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. Class A Actuals & Estimates (NASDAQ:TEM) - TradingView
Tempus AI partners with Angiosarcoma Awareness on rare cancer research By Investing.com - Investing.com South Africa
Tempus AI stock jumps on rare cancer research partnership By Investing.com - Investing.com Nigeria
Tempus AI partners with Angiosarcoma Awareness on rare cancer research - Investing.com
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers - marketscreener.com
TEM Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to sales forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Enterprise value to EBIT forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to earnings forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
The pink kinda moving average line is a little problem, the red dashed is certainly a take profit and wait line - Moomoo
Is Tempus AI, Inc. (TEM) Among the Best AI Drug Discovery Stocks to Buy According to Hedge Funds? - Insider Monkey
Redditors Think Tempus AI (TEM) Still Has 10X Potential - Yahoo Finance
10 Stocks That Will 10X According to Social Media - Insider Monkey
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Tempus AI Tumbles as Lock-Up Expiry Spooks Investors - TipRanks
Chicago has a new highest-paid CEO - Crain's Chicago Business
Tempus AI, Inc. (TEM) Stock Analysis: Unpacking The 30.87% Upside Potential For Investors - DirectorsTalk Interviews
Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI? - simplywall.st
Caitong International Asset Management Co. Ltd Acquires 27,022 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus finance chief joins Needham healthcare event on April 14 - Stock Titan
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.33%
4.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):